Stocks Under $10: New York & Co., Inc

Richard Suttmeier  |

New York & Co Inc (NWY) – ($5.55) has been downgraded to Sell from Hold according to ValuEngine with fair value at $4.99, which makes the stock 11.2% overvalued. The one-year price target is $4.93. ValuEngine Profile – “New York & Company, Inc. is a leading specialty retailer of fashion-oriented, moderately-priced women's apparel. The Company's proprietary branded New York & Company merchandise is sold exclusively through its national network of retail stores.”

 

Analysis – The daily chart for NWY shows overbought momentum with the stock above its 21-day, 50-day and 200-day simple moving averages at $4.85, $4.49 and $3.96. My semiannual value level is $4.97 with a weekly pivot at $5.32 and the recent high at $5.86.

Courtesy of Thomson / Reuters

 

Ticker

Company Name

Mkt Price

Fair Value

One-Year Price Target

Last 12-Mon Retn (%)

5-Yr Avg Retn (%)

P/E Ratio

NWY

NEW YORK & COMPANY

5.55

4.99

4.93

57.22

-12.93

46.25

 

If you have any questions, please contact me at Rsuttmeier@gmail.com.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
NWY New York & Company Inc. 4.92 0.00 0.00 0 Trade
RBSPRPCL Royal Bank of Scotland n/a n/a n/a 0 Trade

Comments

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…